Pfizer vs AbbVie: What's the Better Dividend Stock for Investors in 2026?
Both of these stocks pay more than double the S&P 500 average of 1.1%.
Overview
AbbVie (NYSE: ABBV) and Pfizer (NYSE: PFE) are two top healthcare stocks that pay above-average dividends. Both may be compelling options for investors to consider.
AbbVie pays a more modest yield, but it has been increasing its dividend at a high rate in recent years. Pfizer, meanwhile, pays a much higher amount and can be attractive to investors who don't want to wait a long time before they start generating a lot in dividends. Which one is the better option right now?
Image source: Getty Images.
Details
Source
Originally published at www.fool.com.
Related Articles
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.